Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
IHH has a solid footprint across key Asian markets, so their earnings growth should remain steady as medical inflation stays high. If they maintain decent margins while keeping debt manageable, this stock is a reliable long-term play for your portfolio.
IHH got that solid regional moat with their premium network that keep patients coming back no matter what. Unless their expansion plan kana delay badly, this one confirm plus chop can hold for long term steady growth.
That regional footprint is super solid because people confirm will pay for good healthcare even when economy turns bad. Unless they anyhow expand and burn cash, this stock steady confirm can keep for long term wealth building.
IHH definitely got that defensive moat sorted since medical needs never really go out of style during a downturn. As long as management keeps their capital expenditure in check and avoids over-leveraging, this one is a solid compounding machine for your portfolio.
Last year AGM gave out premium health vouchers and wellness sets, which is quite a solid perk for us shareholders. With their strong regional expansion and steady earnings, I think IHH is definitely a stock worth holding for the long run.
That freebie game is honestly just a small bonus compared to how they dominate the premium hospital scene across the region. As long as they keep expanding and the earnings stay solid, this one is definitely a steady keeper for the long haul.
IHH Healthcare Bhd is expected to deliver a stronger quarter-on-quarter financial performance in the fourth quarter of this year (4Q25) led primarily by its Singapore and Turkiye operations
